818 case studies, 48 vendors.
Every named use case, customer story and success story we could find published on a vendor’s own site — not press coverage, not aggregators, not our summary of them. Organised the way we organise everything else here: by where the work sits in the AI use-case lifecycle. The customer and the technologies named in each story are tagged below its headline; unnamed customers are the vendor’s own choice to anonymise, not a gap in the research.
Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.
Collibra38
- 01Centralized AI governance framework with risk-tiered workflows for safety-critical mining operations
- 02Data governance + AI governance frameworks across 95 markets
- 03European DIY/home-improvement retailer building organization-wide data governance
- 04Integrated Collibra Business Glossary into Tableau/workflows for standardized term definitions
- 05Data fabric implementation to increase data transparency and value
- 06Unified data governance for GDPR/BCBS 239 compliance, bridging risk & compliance silos
- 07Built a cloud-based "Data Governance Center" unifying metadata, glossary, and quality metrics
- 08Uses data to improve efficiency, regulatory compliance, and customer service
- 09Data governance/quality program establishing data ownership and automated quality checks
- 10Built an internal data marketplace for employees to share/access data and build new products
- 11Data management to build personalized insurance products (life, property, casualty, borrower
- 12Data governance to shift from retrospective reporting to predictive insight across 15 country affiliates, deployed in <2 months
- 13Norway's largest bank consolidated 900+ data silos, enabled churn prediction and benchmark reporting
- 14Data governance supporting renewable energy production and carbon-neutrality goals
- 15Reduced insurance claims-denial anomaly detection from six weeks to one day via governance/quality (30M patients/yr, 1,000+ sites
- 16Centralized data platform to optimize pipelines and speed new data-product delivery
- 17Eliminated duplicate data spend and improved quality by cataloging master data sources
- 18Centralized governance platform unifying mainframes, warehouses, Hadoop, and cloud for 2,000+ data users
- 19Unified clinical/business metrics (45+ DBs, 850+ metrics), cut financial analysis time 50%
- 20First end-to-end data governance program at scale in Portugal (with Deloitte
- 21Unified governance platform for a single source of truth across 80+ operating companies
- 22Becoming a data-driven organization via consistent, trusted data availability
- 23Unified 40 siloed glossaries into one business glossary (4,000+ terms/KPIs) across European DIY retail brands
- 24Using data as a core asset to accelerate digital transformation
- 25Expedites product time-to-market through improved data accessibility/governance
- 26Modernizing data architecture with Collibra + Databricks, governance by design
- 27Business-led governance program consolidating fragmented data dictionaries across 160+ stewards
- 28Data Quality & Observability plus Data Catalog for better decision-making
- 29Built "Advana," a centralized platform to govern enterprise data across military services
- 30Shifting from one-off data projects to reusable, governed data products
- 31Unified siloed data across on-prem/cloud for a German insurer
- 32End-to-end view of technical data for regulatory compliance
- 33Data-quality "system of engagement" to reduce risk
- 34Centralized data catalog cut data-search time from hours to minutes
- 35Democratized data access to find/trust/use data across the org
- 36Building a UC-wide medical/healthcare research data warehouse
- 37Cut data curation/governance time from weeks to seconds for personalized learning
- 38Enterprise data governance/metadata management across legacy systems
Domino Data Lab17
- 01Accelerated time to regulatory submission by modernizing vaccine and pharmaceutical development processes on one platform
- 02Presented on using Domino for multi-GPU deep-learning (computer-vision/histopathology) models for precision oncology, 10x faster model development
- 03Deployed Domino's Enterprise MLOps platform as an "FDA-qualified research system of record," letting researchers test tens of thousands of hypotheses with full reproducibility
- 04Health and life sciences customer story (page exists; specific metrics not extracted
- 05Improved trustworthiness of mine-detection intelligence models
- 06Used data science to transform value delivery to advertisers, viewers and distribution partners
- 07Faster claims processing and faster model development
- 08Financial-services data science use case (not industry-relevant to pharma
- 09Insurance data science use case (not pharma-relevant
- 10Financial-services use case (not pharma-relevant
- 11Building a unified Scientific Compute Environment (SCE) at scale
- 12Scaling enterprise data science across drug development
- 13Reproducible AI as a property of the platform
- 14Standardizing on one SCE
- 15How UCB modernized its SCE
- 16Data science innovation across healthcare (webinar
- 17Non-pharma video sessions also present in the resource library (governance, data collaboration, agentic AI architecture) — not detailed here as out of scope
Snorkel AI16
- 01Built a document-classification system to identify HER2 protein status in patient records, 93% accuracy, automating clinical-trial screening
- 02Enhanced decision-making resilience for Indo-Pacific operations tracking
- 03Improved customer-support agent response times to under 3 seconds
- 04Achieved 99% accuracy with an AI-powered sales-productivity platform
- 05Deployed production AI in under 60 days, accelerating claims/subrogation review 67%
- 06Automated CLO contract review, 94% end-user acceptance, hours-to-seconds
- 07Generated decision-grade responses in 15 seconds across data sources
- 08Went from a stalled pilot to $43M annual ROI and 95% accuracy on a customer-facing chatbot
- 09Scaled an agentic AI personal assistant using high-quality synthetic data
- 10Measured and improved virtual-assistant customer experience
- 11Programmatic data-labeling for product-catalog tagging; 99% category win rate, +7pt clickthrough, 10x faster model dev
- 12Built labeling functions that cut manual dataset labeling from months to minutes; 52% performance improvement labeling 6.5M data points for content classifiers
- 13Automated extraction of geological entities from unstructured field reports, hours to seconds
- 14Extracted 50+ attributes from 10-K filings for KYC verification, saved 10,000+ analyst hours
- 15Automated labeling of 10,000+ news articles (hours vs. ~1 year) for an NLP auditing application
- 16Extracted inclusion/exclusion criteria and Schedule of Assessments data from clinical trial protocol PDFs with 95–99% model accuracy, built in weeks instead of months
Dataiku15
- 01Moved from manual spreadsheet-based calculations to Dataiku-driven decision-making; used Dataiku LLM Mesh for healthcare market research, 90% reduction in time-to-insight on GenAI use cases, 600% faster data ingestion on spreadsheet use cases
- 02Used Dataiku to redesign patent/legal workflows with agentic AI; reduced attorney time and cut GenAI project build cycles from months to days
- 03Ran a generative AI training/hackathon with Dataiku that produced working prototypes in under 2 days
- 04GxP-compliant pharmaceutical AI collaboration ("Driving AI Innovation in Life Sciences"
- 05Saved roughly 40 hours/month versus its prior manual process using Dataiku (dedicated story page not directly confirmed live in this pass; reported via Dataiku's own marketing copy)
- 06Transformed data organization and clarity (non-pharma; food/agriculture
- 07Deployed an AI-agent-powered sales model saving 250,000 hours annually (non-pharma
- 08Accelerated analytics delivery 60% and scaled GenAI (non-pharma
- 09Drove business outcomes through data initiatives (non-pharma
- 10Data/AI solutions for energy operations (non-pharma
- 11Market-share insights using AI agents (non-pharma
- 12Unified siloed data into a global AI infrastructure (non-pharma
- 13Improved IT support efficiency using AI agents (non-pharma
- 14Operational excellence via Dataiku (non-pharma
- 15Insurance operations strengthened with data/ML (non-pharma)
Alation13
- 01Used Alation's data-catalog/AI-analytics platform to break down cross-divisional data silos and help identify/treat rare diseases (cited example: identifying patients with transthyretin cardiomyopathy, often misdiagnosed
- 02Democratized biopharmaceutical data access, breaking down silos and increasing discoverability/collaboration with Alation Data Catalog (published as a webinar, not a written case study
- 03Built an "AI-ready" healthcare organization by establishing trust in its data
- 04Reduced risk by improving data consistency
- 05Built a "front door to data intelligence" via comprehensive data governance (non-health; financial services
- 062,500+ users use Alation to find data (non-health
- 07Rebuilt its data foundation across 32,000 employees/150+ facilities (non-health; manufacturing
- 08Built an "AI-ready" environment for autonomous agents via metadata management (non-health
- 09Implemented agentic AI governance, prototypes built in days (non-health
- 10Governed Critical Data Elements across its global supply chain (non-health
- 11Created a single source of truth for supply-chain decisions (non-health
- 12Got AI into production using governance as the foundation (non-health
- 132025 Data Radicals Award winners, cited for metadata strategy (non-health
Databricks11
- 01Pharmaceutical company using Agent Bricks for clinical and pharmacovigilance workflows
- 02Runs its platform on Databricks/AWS to accelerate drug discovery; the Regeneron Genetics Center built one of the largest genetics databases pairing sequenced exomes with EHRs for 400,000+ people
- 03Built a knowledge graph and recommendation engine on Databricks to help scientists mine millions of data points across thousands of sources and generate novel drug-target hypotheses; separately used Agent Bricks to parse 400,000+ clinical trial documents into structured data in under 60 minutes with no code
- 04Transformed its data ecosystem (data silos/redundancy) using Databricks and Unity Catalog; Consumer Health division built reusable core data assets/data products for dashboarding, ad hoc analytics, ML and AI
- 05Replaced an aging data warehouse with Databricks; cut data-processing time 69%, data-availability lag 52%, and operating costs 45%
- 06Healthcare organization using Lakebase for patient, provider and member applications
- 07Healthcare performance-improvement company using Genie for AI-driven analytics/BI
- 08Healthcare story listed under Databricks' healthcare & life sciences customers
- 09Australian public health provider, healthcare story
- 10National digital health service, healthcare story
- 11Described as a Databricks/AWS customer using the Lakehouse Platform in Databricks newsroom/partner material; no dedicated `/customers/amgen` story page could be found live (404) — flagged as unconfirmed/no story page, not fabricated as a full case study
MDClone6
- 01Case study on driving healthcare transformation (data/pharmacy and antimicrobial-stewardship context
- 02Used MDClone's synthetic data to speed research turnaround (same-day answers, 2-3x research output); Sheba is a Newsweek top-10 global hospital 3 years running
- 03Ran 3 pilot projects validating synthetic-data accuracy while preserving patient privacy
- 04Engaged 200+ users with the data platform in under 6 months
- 05Used high-quality synthetic data to support rapid healthcare-innovation initiatives
- 06Generated valid, complete, accurate standardized data from 2.5M unique patient records
Gretel4
- 01Used Gretel's synthetic-data platform to create safe synthetic genomic datasets, enabling genomics research and safe/private data sharing between researchers, healthcare providers and industry
- 02Generated 16M+ synthetic patient records for labor-and-delivery data to train ML forecasting models while preserving privacy
- 03Turned synthetic data into a strategic-growth capability (finance; non-pharma) — referenced on Gretel's finance solutions page, dedicated case-study URL not directly resolved in this pass
- 04Synthetic time-series data for cross-institution use (finance; non-pharma) — referenced on Gretel's finance solutions page, dedicated case-study URL not directly resolved in this pass
Build
Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
AWS47
- 01AI-powered assistant for company-policy Q&A, used by over 80% of employees
- 02Generative AI for target identification on resilient cloud infrastructure
- 03AI-powered agent for natural-language access to clinical trial data
- 04Cloud-based genomics-sequencing data processing at scale
- 05Reduces analysis time 80% and storage costs 90% with Amazon HealthOmics
- 06AI to achieve global scale for treatment delivery
- 07Transforms personalized cancer treatment with AI on AWS
- 08Building the world's first DNA search engine on AWS
- 09Reduces false rejects 50% across production lines using generative AI
- 10Created a unified clinical data layer, accelerating processes
- 11Built the Change Assessment Knowledge Engine (CAKE) on Amazon Neptune, cutting change-assessment duration up to 90%
- 12Slashed clinical documentation time 90% using Claude 3.5 on AWS
- 13Accelerated drug-labeling review with AWS machine learning
- 14Improves operational efficiency with predictive maintenance
- 15Increases forecast accuracy, reduces manual effort
- 16Reduces GxP compliance validation time from weeks to minutes
- 17Leverages Amazon Pharmacy for home delivery of select medications
- 18Transforms product-complaint management, reducing triage time
- 19Modernizes Custom Pak Designer application on AWS
- 20Drives commercial innovation using Amazon Connect and AI
- 21Used AWS compute to initiate clinical trials for 7 drugs (9 more in pipeline
- 22Uses SageMaker to match patients to relevant content across 1.5B+ member-written words
- 23Built Thermo Fisher Cloud to help scientists store/analyze/share data globally
- 24Uses AWS tools to accelerate scientist productivity and lab operations
- 25Runs 90% of computing on AWS (WorkSpaces, Lambda
- 26Scales DNA sequencing globally, cuts costs 100x
- 27Intensive clinical-trial simulations with 98% time savings
- 28Accelerates cancer-research processes to develop therapeutics
- 29Analyzes billions of compounds in one day; compute costs down 50%
- 30Reduced drug-discovery calculation time more than 10x
- 31Built a HIPAA-compliant genomic analysis platform
- 32Enables secure collaboration between researchers and academic labs
- 33Processes whole genomes in minutes to accelerate diagnosis
- 34Saves $800,000/year in drug-discovery compute costs
- 35Manages a pandemic-influenza catalog with 18M simulations
- 36Analyzes 1,150% more reproductive-genetics samples on demand
- 37Processed 800 Alzheimer's genomes in 60 minutes vs. two weeks
- 38Complex genetics analysis at 40% cost savings
- 39Renders cardiac models in 10 minutes vs. a 90-minute industry standard
- 40Scales genome annotation in parallel while managing cost
- 41Potentially cuts genomics research time 50% with AWS Batch
- 42Ran an 80,000+ vCPU job, finishing a workload 33% ahead of schedule
- 43Analyzed 30-40TB of genetic-diversity data in days
- 44Accelerates drug development, saves researchers hundreds of thousands of hours
- 45Screened billions of molecules in under 24 hours for oncology therapeutics
- 46Grew its bioinformatics platform 160% in 18 months, cut costs 87%
- 4799% cost savings; PandaOmics/Chemistry42 on AWS took a fibrosis candidate from target discovery to compound validation in <18 months for $2.6M
Anthropic30
- 01Canadian digital-health/benefits platform; "went all in on Claude in a regulated industry," cut product-development cycle times in half
- 02Brings Claude to the insurance backbone (adjacent to healthcare/insurance, not pharma-specific)
- 03Integrates Claude into its internal "Concierge" app for enterprise-wide efficiency across the value chain
- 04Connector linking Claude responses back to experimental data, notebooks and records
- 05Collaborates with Manifold on Terra to build AI agents for scientists
- 06Connector enabling single-cell/spatial analysis via natural-language conversation with Claude
- 07Uses Claude to streamline drug-to-market processes and produce GxP-compliant outputs from clinical data
- 08Builds transparent, auditable healthcare-analytics solutions for regulated environments with Claude
- 09Uses Claude for document/content automation in pharma development (see also dedicated case study below)
- 10Building "Paper2Agent," turning research papers into interactive AI agents ("virtual corresponding authors")
- 11Pairs life-sciences sector expertise with Claude to reimagine clinical, regulatory and commercial operations
- 12Uses Claude Code to accelerate software development "up to 10x faster in some cases."
- 13Built a bioinformatics AI agent on Claude for research workflows
- 14Uses Claude to model biological data and advance life-science discovery
- 15Builds AI agents translating scientific questions into technical execution across specialized datasets
- 16Uses Claude for bioinformatics and literature-analysis workflows
- 17Uses Claude Code and Claude agents with MCP servers to predict drug toxicity
- 18Dedicated case study: cut clinical study report writing from ~12 weeks to ~10 minutes via "NovoScribe," an AI documentation platform built with Claude Code, aiming to automate full Common Technical Document (CTD) production
- 19Health system applying Claude with a Constitutional-AI safety approach
- 20Healthcare startup building safety-focused clinical applications on Claude
- 21Healthcare software company leveraging Claude for clinical products
- 22Medical-records AI platform deployed via Claude on Amazon Bedrock
- 23Computational-biology firm using Claude Opus 4.5 for coding and scientific figure analysis
- 24Medical AI company citing Claude's reasoning and safety design
- 25Oncology real-world-evidence company; researchers now converse directly with datasets via Claude
- 26Life-sciences software platform combining Veeva's applications/data with Claude for industry-specific agentic AI
- 27Converts clinical processes into compliant AI agents with Claude
- 28Healthcare performance-improvement network (4,400+ organizations) using Claude for workflow automation
- 29Ambient clinical-documentation automation built on Claude
- 30Healthcare AI startup using Claude for clinical data extraction/QA
IQVIA27
- 01Integrated pharmacovigilance tech + services solution; Vigilance Detect reviewed 250,000+ records in under two months, auto-filtering 15,000+
- 02Overcoming the challenges of managing regulatory information with a cloud-based Regulatory Intelligence platform
- 03Vigilance Detect case study brochure
- 04Complex workflow and data collection via the IQVIA Research Management Platform for an investigational digital slide-scanner study
- 05Integrated search content strategy
- 06Advanced patient finding and disease modeling using AI/ML with real-world data assets
- 07Closing data gaps
- 08Revealing the treatment landscape and patient pathways in a new market
- 09Building a compliance program from the ground up for a first US launch
- 10Healthcare insights through AI and machine learning (real-world data + AI/ML for clinical and commercial success
- 11AI case study: increased precision of target patient identification 15x and HCP linkage 10x
- 12Improving patient profiling and physician targeting by combining fragmented data sources
- 13Respiratory treatment research using real-world data and AI/ML
- 14Meeting global transparency-reporting requirements across regions
- 15Digital-first education and support program for caregivers of children with a rare brain disease
- 16Critical milestones achieved ahead of schedule for a Phase III lung-cancer (ALK inhibitor, NSCLC) trial
- 17IQVIA Investigator Site Portal enterprise implementation
- 18Transforming oncology research with an end-to-end patient-experience data approach (COA/eCOA
- 19Fast-tracking clinical trials using NLP to extract oncology/diabetes trial data, cutting cost/time/errors
- 20Improving predictive precision of oncology (CAR-T) patient modeling with enriched data via Integrated Field Alerts
- 21Removing barriers, restoring hope: transforming access to immunotherapy via patient-access/financial-assistance programs
- 22Health data transformation solutions integrated with client's big-data platform (NLP
- 23Adapting to COVID-19: adjudication and oversight group management
- 24IQVIA Alerts cut sales reps' lead-to-engagement time from 5 weeks to 48 hours
- 25How emerging biopharma companies can successfully launch their asset (Launch Excellence
- 26Accelerating market expansion with end-to-end HCP/O engagement services
- 27Partnering with IQVIA to advance healthcare innovation
Google21
- 01Built an AI-native operating system for drug discovery on Google Cloud, using deep learning to speed development and success rate of new treatments
- 02AI/automation drug-development company; uses Google Cloud GPU/VM instances to accelerate drug discovery and lower computing costs
- 03AI-based computational disease models on Google Cloud to help pharma shorten clinical trials and cut drug-development costs
- 04Oncology biotech uses Google Cloud to scale molecular dynamics simulations, cutting simulation time from weeks to overnight and false positives by 50%
- 05Built its protein-design platform (used across pharma/chemicals/food/ag R&D) on Google Cloud
- 06AI-driven drug discovery company; moved to GKE for flexible, scalable protein-structure processing (millions of structures)
- 07Combines microscopy + AI on Google Cloud to help pharma develop new drugs and enable precision oncology
- 08Accelerated discovery of new materials/therapeutics using Google Cloud, with significant power/cost/time savings
- 09Moved its data stack to Google Cloud (BigQuery, Vertex AI, Looker) for supply-chain optimization and product recommendations
- 10AI mobile-health platform; 35,000+ consumers use it to monitor health / join research trials, built on Google Cloud
- 11AI research assistant achieving 95% accuracy extracting/summarizing medical-research literature data on Google Cloud
- 12AI patient-scheduling agent ("Asa") tackling the $150B missed-appointment problem, built on Google Cloud (tagged Healthcare + Life Sciences)
- 13Knolens platform delivers always-on AI for life-sciences (clinical trials, regulatory filings, literature) on Google Cloud
- 14Google Cloud + Localyse solve genomics-pipeline and app-development challenges
- 15Google Cloud powers a patient-record/genetic-data warehouse to personalize diagnosis, treatment and therapy development
- 16Interview-format case study on Google Cloud's transform hub: Bayer's head of applied imaging/innovation discusses generative AI across research and regulatory documentation
- 17Homegrown Gemini-based agent accelerates workflows 70% and saves $2.3M. — referenced on cloud.google.com/blog (healthcare-life-sciences topic hub); exact case-study URL not independently confirmed
- 18AlphaFold 3 & drug discovery blog — DeepMind's own blog names Schrödinger as a partner applying AlphaFold alongside its physics-based software to design selective therapeutic molecules
- 19Novartis — Strategic research collaboration (announced Jan 2024, expanded Feb 2025) to discover small-molecule therapeutics against challenging targets (up to 6 programs)
- 20Eli Lilly and Company — Strategic partnership to discover small-molecule therapeutics against undisclosed targets using Isomorphic's AI drug-design engine
- 21Johnson & Johnson — Multi-target, cross-modality collaboration combining AI drug design with J&J's discovery expertise (small molecules + biologics) for hard-to-treat diseases
Certara15
- 01Cut QC time for regulatory submissions from hours to minutes using GlobalSubmit
- 02Shortened design-make-test-analyze discovery cycle using D360
- 03Enhanced pharmacokinetics workflows with a cloud-based PK solution
- 04Standardized real-world rare-disease data for FDA compliance
- 05Fast-tracked FDA approval of sunvozertinib for NSCLC via pharmacometrics
- 06Communicated clinical/economic value using BaseCase interactive apps (Abilify Maintena
- 07PBPK modeling of Asciminib streamlined development, avoiding 10+ clinical studies
- 08Fast-tracked Nurtec ODT approval using PBPK modeling, skipping a Phase I study
- 09Transformed study metadata management with Pinnacle 21 Enterprise
- 10De-risking Phase 3 rheumatoid arthritis trials with model-based meta-analysis (MBMA
- 11RsNLME solved a PK/PD convergence challenge other software couldn't
- 12Model-informed development accelerated a transformative sleeping-sickness treatment
- 13Expert guidance streamlined timely FDA approval for metastatic colorectal cancer
- 14Integrated PK/PD modeling and machine learning to support CNS compound selection
- 15Accelerated antibody-drug-conjugate approval through expert modeling and data rescue
OpenAI10
- 01OpenAI's dedicated healthcare vertical page/launch post
- 02Frontier reasoning model built for biology, drug discovery and translational medicine; named qualified customers include Amgen, Moderna, Allen Institute, and Thermo Fisher Scientific
- 03Follow-up update to the life-sciences model
- 04"How Amgen uses GPT-5": Amgen applies GPT-5/frontier models to help accelerate delivery of potential new therapies; found GPT-5 met scientific-accuracy standards
- 05Moderna and OpenAI partner to accelerate development of treatments; ChatGPT Enterprise deployed to thousands of employees company-wide
- 06Longevity biotech collaborated with OpenAI to build and research GPT-4b micro, a version of GPT-4o specialized for protein engineering
- 07OpenAI-published benchmark (750 expert-authored tasks across 7 life-science workflows/domains) — not a customer story but a life-sciences-specific artifact on OpenAI's own site
- 08Partnership referenced within the GPT-Rosalind announcement as a named qualified customer for the life-sciences model (no separate dedicated story page found)
- 09Referenced within the GPT-Rosalind materials as leveraging frontier AI to help researchers analyze complex datasets and test hypotheses faster (no separate dedicated story page confirmed)
- 10Three-way collaboration (Sanofi, Formation Bio, OpenAI) to fine-tune models on Sanofi data and build drug-development agents (Muse tool for trial recruitment); could not confirm a dedicated openai.com story page exists (search only surfaced third-party press coverage) — flagged as unconfirmed on-site presence
Schrödinger10
- 01Hit-to-development-candidate in 10 months: rapid discovery of a novel, potent MALT1 inhibitor (SGR-1505) using large-scale virtual screening of 8.2B compounds
- 02Design of a highly selective, allosteric, picomolar TYK2 inhibitor using novel FEP+ strategies
- 03Design of a novel, potent CDC7 inhibitor development candidate with high ligand efficiency and optimized properties
- 04Discovery of a novel, potent ACC inhibitor driven by computationally guided design
- 05High-precision, computationally guided discovery of highly selective Wee1 inhibitors
- 06Enables drug discovery using CDD Vault (with Schrödinger platform integration
- 07Leverages a digital chemistry strategy (LiveDesign) to design α4β7 integrin inhibitors
- 08Advancing lipid nanoparticle (LNP) development with structure-based modeling platform and services
- 09Characterizing lipid nanoparticle self-assembly and structure using coarse-grained simulations
- 10Advancing the design and optimization of drug formulations with combined computational and experimental approaches
Iktos9
- 01Integrated drug-discovery collaboration (Jan 2026
- 02Multi-target strategic collaboration, potential deal value >€1B (Jan 2026
- 03Novel small-molecule amylin-receptor agonists for obesity, diabetes, cardiometabolic disease (Jan 2025
- 04Partnership combining Reaxys chemistry database with Iktos AI for a predictive retrosynthesis platform (Mar 2024
- 05Collaboration to develop next-generation HDAC inhibitors for non-oncological diseases (Jun 2024
- 06Iktos AI de novo design applied to select Pfizer small-molecule discovery programs (2021
- 07Additional AI-for-new-drug-design collaboration (Nov 2020
- 08Collaboration in AI for drug design (Jun 2022
- 09Partnership in anti-malarial drug discovery (Nov 2022
Microsoft Azure7
- 01Deployed a governed AI reasoning agent on Azure so researchers analyze clinical data and test hypotheses in minutes instead of weeks
- 02Built an AI platform on Azure with Microsoft Research; predictive AI models for cardiovascular-disease risk outperform existing clinical standards
- 03Built a research collaboration platform (multi-cloud) on Azure DevOps + GitHub, linking clinical and academic partners
- 04Generates patient test results much faster using Azure
- 05Modernized data infrastructure, unified siloed archives, reduced patient length-of-stay via dashboards, automated insurance-card scanning with Azure AI Document Intelligence
- 06Migrated Epic® environment to Azure, integrated Teams with Epic
- 07Migrated Epic® to Azure and secured patient records with Microsoft Defender
Insilico Medicine7
- 01Rentosertib (ISM001-055), a TNIK inhibitor for idiopathic pulmonary fibrosis: first drug with both an AI-discovered target and AI-designed molecule to reach Phase II; preclinical candidate nomination in 18 months (vs. ~4.5-year industry average) after synthesizing only 78 molecules; Phase IIa showed dose-dependent lung-function improvement
- 02DDR1 kinase inhibitor: proof-of-concept identifying potent inhibitors in 21 days using generative chemistry (Chemistry42
- 03QPCTL immuno-oncology program: candidate nomination in 9 months, co-developed with Fosun
- 04~$1.2B collaboration referenced as a partnership milestone
- 05$80M upfront licensing deal for ISM3091
- 06Partnership potentially worth >$500M
- 07Partnership worth >$100M
Palantir3
- 01Healthcare-system partnership with Palantir (ontology-driven platform; specific workflow not confirmable via static fetch
- 02Clinical teams use Palantir's ontology platform to navigate systems and enroll patients from one place, submitting bed-placement requests in a single click
- 03Major US healthcare distributor uses Foundry to build an end-to-end distribution network for delivering lifesaving products
Ship
Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Veeva Systems44
- 01Transforming content operations for 2x faster time to market
- 02Compliant conversational AI (chat) for improved accessibility
- 03Website analytics and patient insights via Ostro
- 04Smarter targeting to reach underserved patient populations
- 05Agile territory strategies to scale pre-commercial field teams
- 06Unified regulatory data/processes for cross-functional alignment
- 07Transformed patient experience with Vault Patient CRM
- 08Fast-track to agentic call reporting with Vault CRM
- 09Architecting the AI-ready enterprise
- 10Generating commercial evidence with agentic call reporting
- 11Clinical data "one-stop shop"
- 12Patient engagement and ROI with scalable eCOA
- 13Faster trial setup and shorter cycles with Veeva Clinical Data
- 14Reducing site and patient burden
- 15Streamlining clinical study training
- 16Unified clinical operations platform, efficiency/collaboration
- 17Passes inspection with no findings
- 18Standard site experience via Site Connect
- 19Selected Veeva Vault CRM (announcement
- 20Selected Veeva Vault CRM (announcement
- 21Selected Veeva Vault CRM (announcement
- 22Launch excellence with a connected ecosystem
- 23More effective key account management
- 24Connected data unlocks value across commercial planning/execution
- 25Accelerating time to diagnosis for ultra-rare diseases via Veeva Compass
- 26One platform across development; less time finding data
- 27Eliminating workarounds, streamlining collaboration
- 28Cross-functional data foundation for rapid growth
- 29Data foundation for process efficiency and scaling AI
- 30Uncovering critical signals to drive strategic action
- 31Scientific communication foundation for launch
- 32Risk-based, audit-ready training
- 33Unified digital validation for rapid manufacturing growth
- 34Efficiency and compliance with unified quality
- 35Digital-first quality at the heart of QC lab
- 36Scaling globally by harmonizing data with unified RIM
- 37Accelerating RIM deployment with an agile approach
- 38Increasing submissions efficiency with continuous publishing
- 39Gains efficiency with unified safety system
- 40Increasing efficiency by harmonizing data across functions
- 41Reducing case processing time/costs with in-house safety
- 42Operational excellence via deeper data understanding
- 43Connecting data on a single development platform for efficiency
- 44Tips for proactively managing MedTech Vault
Kneat20
- 01Digitized 7 validation processes globally across 27 sites; >50% cycle-time reduction, replaced 3 QMS systems
- 02Built a state-of-the-art digital validation program from the ground up
- 03Electronic logbooks; $500,000 in savings across validation use cases
- 04Harmonized global validation processes while maintaining site flexibility
- 05Accelerated validation timelines, enhanced data integrity
- 06Enabled a data-driven future via CSV digitalization
- 0720-25% cost savings, 30-40% cycle-time reduction in commissioning & qualification
- 08Digitalized validation across 25+ sites, 24/7 visibility
- 09Streamlined C&Q and CSV with Kneat + VEQTOR partnership
- 10Cut CAPA/change-control time in half, 40% savings on test-script execution
- 11Rolled out validation across European and North American operations
- 1288% time saving on URS
- 13Reduced validation labor hours by 65%
- 14Digitalized analytical instrument validation for "Lab of the Future"
- 15Digitized entire validation lifecycle; >100% productivity leap
- 16Improved productivity/compliance (Kneat customer since 2014
- 17Moved from paper-based to digital validation; gains in 5 months
- 18Digitized all validation processes; 50% cycle-time reduction
- 19Transitioned from paper-based to digital validation globally (video story, no dedicated text case-study URL surfaced
- 20Digitalized CQV processes using Kneat Gx (video story, no dedicated text case-study URL surfaced
Medidata19
- 01Data management transformation using Medidata's integrated product suite — (no dedicated case-study URL surfaced; featured on customer-testimonials page
- 02Strategic partnership to embed Medidata AI across the full trial lifecycle
- 03Deployed Medidata Study Build AI (Designer) to accelerate global oncology pipeline
- 04Replaced delayed site payments with Medidata Site Payments Managed Services
- 05Streamlined oncology trials on the Medidata platform (video case study
- 06Used Rave EDC to improve patient screening
- 07Gained precedent-setting FDA approval for a hybrid synthetic control arm in a Phase 3 glioblastoma trial
- 08Accelerated complex trial completion, superior patient/site experience
- 09Reimagined next-gen clinical trial innovation with Medidata AI-powered experiences
- 10Expanded collaboration for patient-centric studies
- 11Extended 15-year partnership by an additional five years
- 12Extended collaboration to improve patient centricity and trial efficiency
- 13Pharmacovigilance via Rave Safety Gateway (with EXTEDO
- 14Used Rave EDC + Rave RTSM to support adaptive trial design via custom functions
- 15Increased rare-disease trial site count by 50% with Acorn AI Intelligent Trials
- 16Fast-growing pharma used Medidata CTMS to work effectively with a resource-constrained team
- 17Used Acorn AI's commercial data management tech (STRATA + LUMEN Insights) for U.S. relaunch of SYLVANT — (referenced in search index, no single dedicated URL captured
- 18Long-time Medidata customer (since 2016), efficiencies bringing rare-disease medicines to patients — (referenced on customer-testimonials page, no dedicated URL
- 19Each appear as named quotes/testimonials on the customer-testimonials page without individual dedicated case-study URLs
Oracle12
- 01Elevated pharmacovigilance safety with Oracle Argus and Empirica; significant reduction in reporting time
- 02Enhancing efficiency and patient safety with the Oracle Argus platform; AI-driven optimization for drug development programs
- 03Gains more efficient operations using Oracle Argus — (URL not confirmed; title/snippet only
- 04Provides broader pharmacovigilance services after selecting Argus — (URL not confirmed
- 05Considers Oracle Argus the "gold standard" in safety — (URL not confirmed
- 06Spotlights a two-decade partnership with Oracle Argus — (URL not confirmed
- 07Greater/faster insight into product safety, improved productivity via Argus — (URL not confirmed
- 08Referenced as an Argus customer story — (URL not confirmed
- 09Trusts Oracle Argus for safety case management — (URL not confirmed
- 10Drives clinical operations efficiency with Oracle Siebel CTMS — (URL not confirmed
- 11Partners with Oracle Clinical One to deliver hybrid clinical trials — (URL not confirmed
- 12Named in Oracle Life Sciences customer-success search results; individual URLs/descriptions not confirmed in this pass
ArisGlobal11
- 01Realizing overall business improvements/efficiencies with LifeSphere CTMS
- 02Register enables compliance and regulatory tracking
- 03Adopted LifeSphere LitPro to automate literature search/monitoring
- 04Selected ArisGlobal's cloud drug safety database; submitted 33,000 cases to FDA within 2 months of signing
- 05Manages clinical and pharmacovigilance cases across 30+ countries
- 06Selected LifeSphere for SUSAR reporting
- 07Triages inbound adverse event reports (agXchange IRT integrated with Argus
- 08Partners with ArisGlobal to manage clinical trials
- 09Modernized safety operations with AI; 25% efficiency gains in PV case intake/processing
- 10Meets immediate and future needs with LifeSphere Clinical Systems — (URL not directly confirmed on arisglobal.com; found via FeaturedCustomers aggregator
- 11Embraces LifeSphere ("The Blueprint") for efficiency and accuracy — (title only, URL not confirmed
Unlearn.AI10
- 01Partnered on ALS Digital Twin Group database for Phase 1/2 trial design
- 02Assessed digital twins for variance reduction/sample-size savings in Alzheimer's Phase 2 trial (AAIC 2024 poster
- 03Digital twins as a new lens for interpreting biomarker trends (AD/PD Vienna 2025 presentation
- 04Accelerated Alzheimer's trials using generative ML disease-progression forecasts (AAIC 2024 poster
- 05Evaluated digital-twins methodology using completed Alzheimer's Phase 2 data (AAIC 2022 presentation
- 06Used digital twins in a Phase 2a trial to predict Alzheimer's progression (AD/PD Boston 2025
- 07Applied digital twins to improve confidence in early-stage ALS trials (2024 ALS/MND presentation
- 08Streamlined QRL-201 randomized control trial efficiency via digital twins (Nov 2024 Summit
- 09Incorporated digital twins into SOL-257 trial design for data-driven decisions
- 10Applied digital twins to single-arm trial exploratory analyses
ValGenesis8
- 01Launched ValGenesis iVal in 97 days; moved off paper; saved 20-25 hrs/week; recouped 50% of investment in 20 weeks
- 02Transformed continuous process verification (CPV) approach via ValGenesis iCPV
- 03Aligned ValGenesis with a new computer system validation (CSV) program; identified process improvements
- 04Transitioned from paper-based to digital validation during an ERP upgrade
- 05Eliminated legibility/data-accuracy concerns by adopting digital validation documentation
- 06Implemented standardized validation management; impressed FDA inspectors
- 07Cut CSV process steps 40%, validation cycle time down 25% via integrated processes — (URL not separately confirmed; referenced in ValGenesis blog/resource content
- 08Digital transformation journey toward full digitalization of validation processes — (URL not separately confirmed; referenced in ValGenesis blog/resource content
Generis6
- 01Migrated 900,000 regulatory documents from legacy Documentum to CARA, serving 85,000 users
- 02Consolidated 65 million documents (13 TB) across two repositories via CARA during ongoing archiving
- 03Unified 12 siloed systems (18 million documents) into one CARA instance for 85,000 users
- 04Integrated QMS, RIM, and safety processes on the CARA Life Sciences Platform
- 05German pharma (500 users) implemented CARA for unified data management since 2022
- 06Transitioned from legacy systems to CARA for improved UX across global operations (Pfizer also separately reported consolidating 4 legacy systems / 18M docs / 40,000 users
Saama5
- 01Agentic transformation bridging data governance and care delivery
- 02Centralized patient/site data for faster insights ("More Data, More Insights, More Progress"
- 03Centralized data across 40+ systems via Data Hub; 35% faster time to data discovery
- 04Smart Data Quality saved 20,000+ data-manager hours, reconciled 105M data points in 4 months
- 05Source-to-Submission (S2S) cut SDTM mapping time 25%, 70% auto-mapping accuracy
Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.
ServiceNow10
- 01Global life-sciences company's AskHR digital hub (ServiceNow HR Service Delivery + Now Assist) handles 250,000+ requests/year, 75–76% self-submitted, 5,000 knowledge articles at 88% quality rating
- 02Healthcare asset/medical-equipment management company uses the ServiceNow AI platform for technician support; 22% developer-productivity improvement
- 03Unified a multi-vendor IT environment, raising first-contact resolution from 85% to 90.1%
- 04Global medtech company's decade-long shared-services digital transformation (finance, procurement, HR, sales, supplier portal) on ServiceNow
- 05Medical-equipment provider to 3,700+ hospitals; 100+ process improvements, idea-to-production cut to 1 week, faster equipment-repair turnaround
- 06North Carolina health system uses ServiceNow AI/Virtual Agent to speed IT-issue routing and resolution (co-branded HIMSS case study PDF
- 07COVID-19 symptom checker + nurse chatbot built on ServiceNow
- 08IntegrationHub/App Engine cut monthly invoicing effort from 40–80 hours to 13 hours
- 09Described in ServiceNow marketing copy as "fulfilling its life-saving mission" on the platform
- 10Vaccination scheduling, COVID-19 testing, and contact-tracing workflows for 6.5M citizens via Customer Service Management
IBM9
- 01Salesforce + integration platform cut COVID-19 test-result processing from 8 hours to minutes
- 02IBM product engineering/design added medicine management, secure messaging, appointment booking, test results
- 03IBM Blockchain-based encrypted ledger for Electronic Health Records
- 04IBM Consulting modernized legacy Medicaid systems on hybrid cloud
- 05AI/ML-powered Document Intelligence Platform automates invoice/PO/delivery matching
- 06Legacy Watson Health case study for this clinical-trials CRO
- 07IBM MaaS360 + Watson unified endpoint management for IoT/non-standard device IT support
- 08IBM infrastructure work mitigating pharma supply-chain risk post-pandemic
- 09IBM Consulting built "Pulse," a blockchain platform tracking prescription-drug ownership transactions
Credo AI8
- 01HR-tech talent-matching startup achieved EU AI Act compliance ~10x faster using the Credo AI platform
- 02Aerospace/defense customer established lifecycle AI risk management for defense operations
- 03Global energy company unified AI governance across 500+ AI use cases
- 04Global tech company embedded/automated AI governance into enterprise workflows via a 3-step process
- 05Global consumer packaged goods company operationalized responsible AI governance across business units
- 06Scaled generative AI governance in financial services, cutting new-use-case review effort
- 07Global reinsurance provider standardized algorithmic bias assessment/reporting for regulatory compliance
- 08"Accelerating AI Governance Maturity From Principles into Practice" — a webinar, not a case study, featuring Parth Patel (Exec Director, AI & Data Science at Madrigal) discussing how Credo AI's framework complemented Madrigal's internal AI-governance processes
Sware7
- 01Projected to save 1.5 FTE/year on ERP validation; now FDA audit-ready with end-to-end traceable, data-first validation
- 02User-friendly Res_Q software enabled streamlined, access-controlled audits
- 03Res_Q platform + Sware's people resources drove validation time and cost savings
- 04Joint GxP-compliant paperless-workflow offering for life sciences built on Res_Q
- 05Cut validation time 30–40% by centralizing validation across multiple sites on Res_Q
- 06Shifted from CSV to CSA, accelerating validation by 75% and freeing ~1 FTE of labor
- 07Validation workstream execution time cut from days to hours
ModelOp5
- 01Cut AI risk-rating process from two weeks to one day via a Responsible AI framework (presented as a fireside-chat writeup, not a standalone case-study page
- 0250% reduction in time-to-market for bond-trading AI using ModelOp Center
- 03AI model operations at scale, monitoring hundreds of production models
- 04Composite fraud-detection model deployed via ModelOp Center
- 05Near-real-time credit-scoring updates via automated model lifecycle
Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
AlphaSense52
- 013M's healthcare-focused Global Strategy & Market Development team (per the featured exec, whose quote ties the work to "driving healthcare forward") uses AlphaSense to speed up research synthesis and become more responsive to executives
- 02A TCR-based immunotherapy biotech uses AlphaSense as a "one-stop-shop" to accelerate market research within budget constraints
- 03A healthcare-intelligence firm chose AlphaSense for faster, money-saving market and company intelligence
- 04"A BioPharma Insights Company" — Uses AlphaSense to analyze drug projections and access expert interviews for faster, more informed investment decisions
- 05Biotech investment firm — A biotech-focused investment firm specializing in fundamental research uses AlphaSense as a one-stop shop for research content
- 06The ~100-year-old global integrated healthcare services and products company uses AlphaSense to augment its research
- 07The bank's investment-banking/wealth-management team accelerates deal research by 50% with AlphaSense; page is dual-tagged "Financial Services" and "Life Sciences & Healthcare" by AlphaSense (likely reflecting healthcare-sector deal coverage, not that Emirates NBD itself is a life-sciences company
- 08The healthcare group cuts hours from its investor-relations workflow, monitoring market sentiment and keeping messaging consistent across teams
- 09The biotech uses AlphaSense to speed up competitive intelligence by 120x and make faster, data-driven R&D decisions
- 10Merz Aesthetics' Director of Market Intelligence (a "one-woman program") uses AlphaSense's AI search to hit tight earnings-recap deadlines
- 11A competitive-intelligence expert (currently Director of CI at the gene-editing biotech Precision BioSciences, previously at other pharma companies) saves tens of thousands of dollars a year and cuts research time from 24 hours to 30 minutes using AlphaSense
- 12The biopharma royalty company drives efficiency gains, streamlines workflows, and improves knowledge sharing with AlphaSense (30% less time on daily research; 3-4 analysts doing the work of 100+
- 13The competitive-intelligence arm of Cambridge Healthcare Research (serving pharma clients across oncology, rare disease, infectious disease) eliminates research bottlenecks and scales AlphaSense access org-wide
- 14The Italian pharmaceutical group accelerates research with AlphaSense
- 15The women's-health pharma company (fertility, contraception, menopause, uterine health, osteoporosis; 50+ countries) uses AlphaSense to fuel global growth and expansion into new territories
- 16Aerospace company (CI leader) — Uses AlphaSense (WSI) to uncover in-depth research and strategic insights; drives better client service and technology decisions
- 17Saw a 300% increase in team platform engagement after switching to AlphaSense
- 18"a highly regarded asset manager" — A private equity firm known for superior returns saves time on due diligence with AlphaSense
- 19Sell-side equity research analyst — Automates an "onerous" equity research process, likened to how Google automated the library
- 20The consulting/accounting firm cuts research time from hours to minutes, scaling meeting prep and client insight delivery with AlphaSense
- 21Reduces research costs and accelerates decision-making with AlphaSense's AI market-intelligence platform
- 22Saves hundreds of hours gaining access to the right intelligence via AlphaSense
- 23The CPG company's competitive-intelligence analyst tracks competitors and market trends in real time, saving hours of manual research daily
- 24The Director of Competitive Intelligence increases confidence in, and speed of, research — a "double win"
- 25$50B AUM fund (fund of funds) — Sources, underwrites, and structures public/private investments; AI increases efficiency
- 26The Toronto strategy-consulting firm delivers faster client research and market insight with AlphaSense
- 27"global science and technology leader" — A diversified ~70-country company spanning healthcare, industrial, consumer, and electronics escapes "information graveyards" (scattered folders/drives) with AI-driven market intelligence; touches healthcare but is not primarily a pharma/life-sciences company, so not tagged pharma here
- 28Global manufacturing leader — Overcomes information overload and fragmented data sources to accelerate innovation with AI
- 29Global tech company — Moves from alert fatigue to strategic precision, fixing fragmented market monitoring and low-quality data
- 30Private equity leader — Fixes slow, manual market-research processes, inconsistent data, and misinformation risk with AI
- 31Deep-dives into new investment territory (solar) using expert transcripts and targeted company analysis
- 32Cuts research time by 50%, never missing investment opportunities across portfolio companies
- 33Semiconductor leader — A semiconductor giant with 22,000 employees uses AI to monitor competitors and assess investments faster
- 34Large midstream energy company — Tracks industry shifts and accesses broker research to navigate the energy transition
- 35Partners with AlphaSense to transform corporate-strategy workflows, compound knowledge, and drive confident executive decisions
- 36Cuts research time in half finding market intelligence, patents, and industry trends
- 37Portfolio managers save 4-5 hours a week and gain investment confidence via AlphaSense
- 38Unifies investor, corporate, and market intelligence using AlphaSense's Deep Research, Generative Grid, and dashboards
- 39Finds investment insights faster via expert transcripts, smart search, and filtering
- 40Sell-side analyst Howard Mason streamlines coverage of securities and macro-trend content with AlphaSense
- 41An analyst saves 25% of time during earnings season via comprehensive earnings analysis
- 42The competitive-intelligence team tracks competitors and makes strategic decisions faster with expert insights
- 43Achieves sustainability goals with AlphaSense's research platform
- 44Transforms its market-strategy team into a "forge" of shared insight via AlphaSense's AI-powered research infrastructure
- 45Achieves a 4x productivity increase (5 to ~20 reports in 48 hours) with AI-driven market intelligence
- 46Simplifies comprehensive competitive research central to its digital-transformation mission
- 47Uses AlphaSense's agentic AI to revolutionize its market-intelligence process
- 48Cuts research costs and gains deeper market insight, replacing expensive expert networks with AlphaSense Expert Insights
- 49Unlocks confident decision-making via AlphaSense's document search
- 50The Market & Competitive Insights team reduces search time, saves money, and generates new revenue-relevant insight
- 51Uses AlphaSense's generative AI search to track competitors, analyze market trends, and lead sustainable-mining initiatives
- 52A Singapore public/private equity firm transforms its investment-research process, driving speed and conviction with AlphaSense
Optum46
- 01Health system partnership drove a stronger financial future through RCM services
- 02Second case study on revolutionizing its cardiology program with Optum
- 03Contracted clinician describes his experience joining the Optum Network
- 04Physician's transition to value-based care with Optum Network support
- 05How Optum Network support reduced his practice workload
- 06Digital integration case study to reduce administrative burden in assessment programs
- 07CDI/coding technology increased monthly case review average by 22%
- 08Second story: AI helps the health system manage costs and focus on patients, not paperwork
- 09Improved CDI efficiency using Optum technology
- 10Used Optum Market Advantage data to drive health system growth
- 11New billing system reduced bad debt and increased cash
- 12Maintained financial stability during COVID-19 with Optum RCM
- 13Automated online scheduling for COVID-19 vaccinations
- 14Mobile medical clinic bringing care to underserved Nevada communities
- 15Digital payer-channel scheduling increased volumes and cut no-shows
- 16Improved efficiency through an intelligent imaging workflow
- 17RCM services helped the lab navigate difficult reimbursement waters
- 18Boosted EMS billing collections by 40%
- 19Analytics dashboard improved substance-use-disorder program management
- 20New data/analytics approach to Medicaid program management and fraud recovery
- 21Improved RCM and profitability for physician practices
- 22Behavioral health network expanded digital-first patient access via self-scheduling
- 23Simplified mental health access through online/digital scheduling
- 24Optum Serve supports military entrance processing operations
- 25Cooperative purchasing organization streamlines state procurement with Optum
- 26HouseCalls in-home assessments linked to fewer ED visits and hospital stays
- 27Emotional wellbeing/EAP support tailored to firefighters' needs
- 28Corporate health engagement solution to boost employee fitness and wellbeing
- 29Closed care gaps through annual in-home assessments (7.69:1 ROI
- 30Third case study: IT performance services partnership described as "a model IT" relationship
- 31Predictive analytics (Optum One) for population health/chronic disease management
- 32Intelligent Perioperative Suite increased patient throughput and satisfaction
- 33Structured cardiovascular reporting cut unsigned charges within 5 days by 79%
- 34InterQual solutions transformed utilization/case management
- 35Impact Pro drove $1.1M in benefits and productivity gains
- 36Journey to a four-star CMS Star Rating
- 37Tailored financial/emotional wellbeing support eased employee stress
- 38Optum Advocacy solution drove measurable results
- 39Clinical collaboration ensured timely access to HIV PEP medications
- 40Robotic process automation saved 9,465 hours and $950,000 over 5 years
- 41Transition to cloud-native PACS/enterprise imaging
- 42Personal story illustrating women's health support beyond reproductive care
- 43Infusion nurse's quick action credited with saving a patient's life
- 44Case study on investing in employees' financial wellbeing/success
- 45Emotional wellbeing solutions deployed for health care workers
- 46"From transformation to triumph" turnaround case study
Definitive Healthcare45
- 01Powered their HubSpot CRM with Definitive Healthcare data to reduce costs and sharpen go-to-market strategy
- 02Enabled 35–45% more effective budget management
- 03Identified the right markets, driving focused and sustainable growth
- 04Closed 10 deals totaling over $1.3M in 18 months
- 05Optimized sales strategy with better intelligence on health-system relationships
- 06Reduced lead-generation costs using Definitive Healthcare intelligence
- 07Gained ROI through significant weekly time savings
- 08Ramped up business development capabilities
- 09Refined targeting to efficiently pinpoint organizations running cancer clinical trials
- 10Identified new contacts, new markets, and new opportunities
- 11Increased sales-team efficiency with unique customer insights
- 12Closed more deals with healthcare commercial intelligence
- 13Achieving ROI with clinical propensity model targeting
- 14Increasing appointments with targeted service-line marketing campaigns
- 15Understanding the competitive landscape with healthcare commercial intelligence
- 16Informing clinical care programs and partnerships with data and analytics
- 17Identifying relevant KOLs on a global scale
- 18Quickly finding global prospects with healthcare commercial intelligence
- 19Enabling a brand to move from later- to earlier line of therapy
- 20Optimizing promotional planning while reducing consultant dependencies
- 21Optimizing marketing and sales investments across brands and regions
- 22Expanding the HCP target list for a new drug treating a rare disease in children
- 23Accelerating Phase III clinical trial enrollment
- 24Predicting patients with an ultra-rare disease for treatment launch planning
- 25Increased medical affairs engagement by 40% engaging the right rare-disease KOLs
- 26Attracted more healthcare market share by leveraging healthcare commercial intelligence
- 27Year-over-year increase in reorder revenue and procedure volume
- 28Uncovered 15 net-new physicians treating a rare disease
- 29$7M return in the first year through market expansion
- 30Understanding competitive landscape
- 3130% increase in accuracy of market opportunity analysis, driving marketing-campaign success
- 32140 additional highly qualified sales leads identified
- 33Increased stroke-estimate precision to ~90% at key hospitals via elevated sales segmentation/messaging
- 34Converted 12 prospects into clients within 5 months, growing revenue and shortening the sales cycle
- 35900 KOLs uncovered, driving commercial launch success
- 36Building a reliable marketing contact database
- 37Powering commercial teams with a robust CRM
- 38Calculating total addressable market ~7x faster
- 39Driving market expansion by influencing patient referral leakage
- 40Generating new provider referral streams
- 41Powered product launches with claims and affiliations data, used across 52 additional client projects in the following year
- 42Recaptured market share and accelerated revenue growth
- 43Accelerated go-to-market for a new device
- 44Sized and segmented the market for an innovative cancer-treatment device, addressing misdiagnosis/treatment-delay challenges — (referenced via site search; specific URL not directly captured
- 45Featured multi-customer panel video case study
Norstella40
- 01MMIT used NorstellaLinQ to merge unstructured EMR data with structured data to detect disease screening patterns and drive commercialization strategy
- 02MMIT used NorstellaLinQ real-world data to narrow a target patient population and improve physician targeting
- 03MMIT used NorstellaLinQ to give a clearer real-time picture of high-risk patients and the physicians treating them
- 04Panalgo linked unstructured EMR data (via NorstellaLinQ) with closed claims data for an HEOR study on knee arthroplasty, delivering years of longitudinal data in 8 weeks
- 05"NorstellaLinQ: Better together — Getting the full patient picture" use case
- 06CRO used Citeline to validate site/investigator hypotheses for a Phase III oncology "trial rescue," uncovering protocol constraints and competitive-intensity insights
- 07Patient advisory board reviewed Citeline Connect's IRB-approved outreach materials and Clinical Trial Portfolio Websites to improve trial recruitment
- 08"Global Patient Insights" use case: optimized investigator selection and diversity goals for a Phase II mRNA solid-tumor cancer trial
- 09"A Patient-centric Approach to Clinical Trial Site Selection" — Citeline datasets used to match site/investigator selection to IgA nephropathy patient epidemiology
- 10Referenced via search only ("Case Study - Patient Input in Trial Recruitment") — same as Smart Patients entry above (duplicate title indexed differently
- 11Screened 4,700+ oncology assets with a bespoke prioritization model to select 5 in-licensing candidates
- 12Evaluate ran partner search/outreach for two early-stage oncology assets, achieving a 30% response rate and interest from 3 major pharma companies
- 13Evaluate built a 24/7 competitive-intelligence monitoring program shifting the client from reactive to proactive CI
- 14J+D Forecasting overhauled oncology forecasting from fragmented finance-led models to a scalable framework ahead of a Phase III launch
- 15Custom virtual forecasting-training program standardized practices across regional teams
- 16"Case Study Archives" index page exists (evaluate.com/category/case-study/) but its full entry grid could not be enumerated (JS-rendered); the 5 entries above are the ones found, more may exist
- 17Consulting firm used MMIT Analytics and FormTrak to help a pharma client communicate product coverage info to providers
- 18Used MMIT data/insights to achieve 95% payer coverage for a rare disease therapy at launch
- 19Used MMIT's Strategic Launch Report/analogs to build a competitor risk-mitigation strategy
- 20Tracked real-time market access data and identified high-value HCPs for targeted outreach via MMIT's core solutions
- 21Merged unstructured EMR + structured data via NorstellaLinQ to detect disease-screening patterns
- 22How MMIT's Contract Validation solution streamlines rebate/contract-position validation against formularies
- 23Used MMIT real-world data to uncover hidden market-access opportunities
- 24Business-development firm used MMIT's Reach + Directory of Health Plans data to generate medtech leads in the payer space and hit KPIs
- 25Used IDN Formulary Insights to drive utilization gains after favorable-but-underused formulary placement
- 26Mapped a one-year post-launch patient journey by combining open/closed claims with transactional records via a token engine
- 27"Simplify Coverage Checks with BPG" — incorporated BIN/PCN/Group fields into its platform for seamless benefit verification (title truncated in search index; URL not directly confirmed
- 28"Ensure Accurate Reimbursement with MMIT's..." — developed communications about an infusion therapy's new NDC/J-codes to reduce claim denials (title truncated; URL not directly confirmed
- 29"Improving Launch Coverage With Insights" — partnered with MMIT to understand payer perspectives and refine brand messaging (URL not directly confirmed
- 30"From Guesswork to Clarity: Gaining..." — used MMIT Analytics and Searchlight to obtain detailed payer landscape info by geography (title truncated; URL not directly confirmed
- 31ReimbursementCodes case: saved $250K+/year by automating claims review
- 32Research team used Panalgo's IHD Analytics platform to evaluate comorbidities among vitiligo patients from a large U.S. commercial claims database
- 33Nonprofit combined its registry data with external data sources via Panalgo to unlock novel Type 1 diabetes research
- 34Generated HEOR data (via NorstellaLinQ) on cemented vs. uncemented knee arthroplasty, getting years of longitudinal data in 8 weeks
- 35Achieved major cost savings and productivity gains on a clinical-trial-diversity analytics project without hiring/outsourcing
- 36IHD Data Science module accelerated an analytics project from months to weeks
- 37Used unstructured EMR data to expand a rare-disease patient cohort by 1,500% after ICD-10 codes missed patients
- 38Hosted an internal "datathon" using Panalgo's IHD Data Science module to build staff RWD/AI/ML literacy
- 39Replicated a 14-month dissertation analysis (opioid use disorder) in 1 week using Panalgo's self-service platform
- 40Completed analyses informing an observational study design in 6 weeks instead of months
GlobalData25
- 01Used GlobalData's analytical modeling to evaluate expansion across 150+ markets and launched a new non-beer brand in Europe via a strategic partnership
- 02Used GlobalData's combined agribusiness + consumer/retail intelligence to track EU sugar volume consumption by country/category since 2015 for sales, marketing and strategic planning
- 03Same EU sugar-consumption dataset engagement as above, published under a second URL
- 04Commissioned a market-sizing study across liquid food & beverage categories and used GlobalData's model to rank market-entry options, launching a non-beer beverage brand in Europe with a partner
- 05Engaged GlobalData to analyze competitor activity across consumer "demand spaces" to guide where to invest strategically
- 06Commissioned a consumer-spending forecast tied to Taylor Swift's 2024 Eras Tour (survey of 1,500 shoppers), then published the report and ran a themed promo campaign
- 07Used GlobalData's Packaging Intelligence Centre for annual/quarterly dairy- and soft-drinks packaging data across 100+ countries for planning
- 08Commissioned a GlobalData Agribusiness economic-impact analysis on oilseeds/grains/pulses processing's contribution to Canada's economy — (note: title mismatches content — page content is the Canadian farmers' association study, not an apparel printer
- 09Engaged GlobalData to evaluate a small-molecule vs. antibody therapeutic for CMV-infection prevention across 7 major markets (clinical pathway mapping, KOL interviews, forecasting
- 10Used GlobalData's primary/secondary research to build a prospect list and operator briefing on polyester printing businesses in target European markets
- 11Integrated GlobalData's APIs/data feeds into an internal portal to give account teams real-time company/industry/competitor insight
- 12Commissioned market research on the global LPG & ethylene shipping market (key players, growth to 2030) to inform vessel-sizing and expansion decisions
- 13Used GlobalData's financial-health ratings on general insurers to monitor carrier stability and meet regulatory audit requirements
- 14Commissioned a South Asia market study (sizing, competition, soil conditions, regulation) to build a market-entry strategy
- 15Used GlobalData's proprietary Mining Equipment Predictor Model to size demand for a new telescopic tyre-handler attachment
- 16Trend report: 4 food & beverage growth opportunities for 2025 (personalized women's health, sustainability, health-longevity, flavor expansion
- 17Trend report: how cannabis users' consumption behavior differs from other consumers across 5 markets, and the implications for CPG brand strategy
- 18Trend report: 5 foodservice trends for 2025 (multi-channel commerce, promo deals, plant-based, social media, supply-chain transparency); illustrates with unnamed example Pasta Evangelists
- 19Used GlobalData's platform (incl. Malaysia ICT Tracker) for 5+ years for strategic planning, market forecasting and competitive benchmarking in ICT
- 20Used GlobalData's AI Hub (Ava AI Research Analyst) to cut research time from days to hours and improve confidence in insights
- 21Analyst Relations team used GlobalData's AI Hub to streamline research synthesis and democratize market-intelligence access org-wide
- 22Trend/whitepaper: the $417bn smart-cities opportunity and the IoT stack organizations need to capitalize on it
- 23Trend report: MEA trade-corridor infrastructure reshaping construction value (59% of MENA transport/logistics projects concentrated in 2 countries
- 24Trend report: data-center technology convergence amid a $2.5tn global project pipeline and AI-workload challenges
- 25Trend report ("The Race for Speed to Power"): energy-sector dynamics incl. LNG demand forecasts and interconnected energy decisions
Clarivate23
- 01Evolved its commercial, marketing and customer-engagement strategy using Clarivate real-world data and analytics
- 02Used Clarivate/Cortellis IP and business support to advance a blood test for early ovarian cancer detection toward commercialization
- 03Used Clarivate asset/technology and IP valuation expertise to make informed investment decisions in breakthrough biotech and science innovations
- 04Partnered with Clarivate Regulatory Intelligence Tracking Application (companion to Cortellis Regulatory Intelligence) to transform and streamline regulatory workflow
- 05Used a Clarivate patient-journey-mapping framework to integrate patient centricity into its mature/mid-lifecycle brand strategy in Asia Pacific, improving patient outcomes and brand awareness
- 06Used Clarivate's DialogML (with Dialog and Drug Safety Triager) to apply AI/NLP to detect Individual Case Safety Reports (ICSRs) in scientific literature more efficiently for pharmacovigilance
- 07Used Clarivate data to gain detailed insight into the UK rare-disease research landscape and inform future policymaking
- 08Used Cortellis Deals Intelligence together with Cortellis Competitive Intelligence to secure the best price/terms while out-licensing its abuse/overdose-resistant prodrug technology
- 09Used a Clarivate knowledge-graph/drug-repurposing framework spanning Cortellis Drug Discovery Intelligence to identify existing drugs usable as medical countermeasures for chemical-agent exposure
- 10Researchers used Clarivate pathway-analysis tools to let biologists self-serve omics data analysis (freeing up the bioinformatics team) to make go/no-go drug-development decisions
- 11Combined multiple real-world data sources via Clarivate to compare internal sales data against estimated device volumes and sharpen commercial targeting
- 12Used Cortellis granular sites data plus incidence/prevalence and U.S. claims data, and Clarivate Consulting Services, to select trial sites/investigators for a late-stage rare-disease trial
- 13Worked with Clarivate regional regulatory experts and regulatory intelligence solutions to streamline monitoring/distribution of fast-moving global regulatory requirements
- 14Used Clarivate network/biological-mechanism tools to systematically identify and prioritize alternative indications for a promising drug asset in the APAC market
- 15Used a Clarivate knowledge-graph architecture (incl. MetaBase, Cortellis Drug Discovery Intelligence) to integrate clinical multi-omics data with public datasets and understand drug-response mechanisms
- 16Used Clarivate systems-biology/network tools to validate the mechanism of action of a lead kinase inhibitor and identify resistance biomarkers for patient stratification
- 17Ran a compliant digital messaging campaign (GPs and pharmacists) to escalate under-treated severe-asthma patients onto a new product, reportedly driving 350k fewer asthma attacks
- 18Ran an EHR-embedded digital messaging campaign to identify at-risk COPD patients and escalate them to guideline-recommended triple therapy, reportedly driving a 31% increase in triple-therapy prescriptions
- 19Ran a 19-month clinical messaging campaign to drive prescribing of the newly launched product, reportedly achieving an 89% increase in prescriptions
- 20CDK inhibitor class safety) — Illustrates how OFF-X translational safety intelligence can assess whether ocular toxicity is a class effect of CDK inhibitors, using public clinical-hold disclosures as the example
- 21Adverse-event mechanism ID) — Illustrates how the OFF-X Translatability Dashboard can identify plausible mechanisms behind an anaphylactoid reaction seen in a preclinical rat safety study
- 22Lisaftoclax patient-safety profiling) — Illustrates how OFF-X Translational Safety Intelligence uncovered an unexpected patient-condition-specific safety association for the Bcl-2 inhibitor lisaftoclax to inform smarter clinical-trial design
- 23Video customer story (Vidyard modal, not a standalone page) describing a partnership using Clarivate data and technology to help reduce the U.S. child-suicide rate; tagged under the "Life Sciences & Healthcare" segment on the general customer-stories hub
HealthVerity23
- 01Partnered to improve rare-disease campaign targeting using Symphony Health custom audience data and an Audience Quality Index
- 02Used RWE to sharpen launch strategy and prescriber/patient targeting for an oral TYK2 inhibitor in psoriasis
- 03Achieved 26.9x targeting precision in a rare kidney disease campaign via HealthVerity Audiences
- 04Supplemented claims with oncology lab results to narrow 75,395 metastatic breast cancer patients to 1,188 subtype-confirmed patients
- 05Used deeper clinical context via HealthVerity Audiences to more precisely target chronic liver disease patients for a specialty therapy
- 06Used observed clinical signals instead of modeled assumptions to reach a rare hematologic disease patient population
- 07Used HealthVerity eXOs to answer early evidence questions and validate research direction in under an hour
- 08Analyzed GLP-1 persistence and adherence over two years across ~3.9M semaglutide patients
- 09Ran six effectiveness/comparative studies of an anti-seizure medication against competing therapies
- 10Validated whether its target audience had heart failure to get real-time campaign effectiveness insights
- 11Used real-time media attribution to optimize marketing campaigns while staying HIPAA-compliant
- 12Analyzed linked claims/EHR data on high-risk non-muscle-invasive bladder cancer patients who failed BCG therapy, revealing a care gap
- 13Ran a retrospective study of 3,095 HIV/HBV-coinfected adults to find a treatment protecting against liver disease
- 14Evaluated HIV testing patterns among ~983 long-acting injectable cabotegravir (CAB-LA) PrEP users
- 15Demonstrated secure linkage of sensitive federal datasets across two agencies without exposing PII
- 16Found cenobamate monotherapy cut inpatient days and ER visits among 299 epilepsy patients
- 17Studied disparities in OUD treatment outcomes (buprenorphine vs. naltrexone) using Marketplace claims data
- 18Compared virtual vs. in-person physical therapy costs/utilization using closed claims from HealthVerity Marketplace
- 19Ran the SEPRA (SEmaglutide randomized PRAgmatic) trial, using Identity Manager to link 1,278 trial participants to real-world claims (87% tokenized
- 20Combined structured claims with unstructured clinical notes to identify ~287K long COVID patients, 19% more than codes alone
- 21Built a regional analytics platform tracking severe obstetric complications and heart disease by ZIP3 to target local interventions
- 22Uses HealthVerity's data repository to support drug approval processes and AI-driven regulatory decision-making
- 23Partnered via the eXOs platform to give researchers no-code AI analytics tools for RWE research
Merative17
- 01Advances research with diverse, longitudinal MarketScan real-world data
- 02Cloud-based real-world data access via MarketScan to empower researchers, shared as part of Merative's RWD-in-the-cloud journey series
- 03Increased sample size and strengthened insights using longitudinal MarketScan RWD to study medication/pregnancy-outcome associations
- 04Examined variations in elective surgery prices across the US using MarketScan data
- 05Transformed drug-shortage management using OrbitalRX
- 06Gained efficiency and control over clinical trials
- 07Served its expanding clientele with a modular clinical development solution
- 08Accelerated processes across the clinical development life cycle
- 09Reduced overhead, costs, and time by improving the clinical trial process
- 10Case study on clinical development solution adoption
- 11Empowered medical coders with faster, more precise medical coding
- 12The right technology and team helped this CRO focus on client success
- 13Life-saving treatments reach patients faster
- 14Zelta customer-satisfaction case study
- 15Featured Zelta case study
- 16Merge PACS medical-imaging case study
- 17Used Merative Health Insights to measure the impact of employee health on productivity and absenteeism
Datavant14
- 01Ran a 36-week Phase IV study (175 patients, 40 sites) using trial tokenization to link to real-world data, extending effectiveness/safety analysis of a new focal seizure treatment
- 02Built a model (with Datavant matching/linking) to identify hereditary ATTR amyloidosis patients, identifying 60+ new cases
- 03Used Datavant's identity resolution technology to narrow duplicate patient counts by 96 million (22%), producing a higher-quality, more comprehensive real-world dataset
- 04Peer-reviewed studies using patient-level health data connected by Datavant technology to study intervention/policy effects on outcomes
- 05Partnered with Datavant on a flexible, scalable medical coding model to overcome staffing challenges and strengthen compliance
- 06Accessed curated AAO IRIS Registry data to understand disease burden, clinical outcomes, comorbidities, and cost/utilization for rare eye disease patients
- 07Used Datavant Switchboard to connect specialty pharmacy and patient-hub data to real-world data, addressing infusion-therapy treatment discontinuation and improving patient adherence
- 08Transformed risk adjustment and care coordination using Datavant's Clinical Data Platform for real-time, structured clinical data acquisition
- 09Implemented a digital solution for provider-payer collaboration on managed care audit processing
- 10Used 100M+ linked EHR records for near-real-time COVID-19 analysis to guide healthcare policy
- 11Linked oncology diagnostic lab data to assess a blood test's effectiveness in supporting immunotherapy treatment selection for lung cancer
- 12Overview of how Datavant powers external control arms using real-world data, illustrated with an oncology case
- 13Phase III COVID-19 vaccine study using trial tokenization to link to RWD, tracking long-term effectiveness/safety and infection rates beyond the trial period
- 14Connected specialty drug data via Datavant for better physician targeting after a rare-condition drug's sales lagged due to difficulty finding eligible patients
Flatiron Health14
- 01Used Flatiron's Enhanced Data Mart for real-world/external-control analysis supporting Canadian HTA reimbursement approval of a BRAF V600E–targeted NSCLC treatment
- 02Used Flatiron's Clinical Genomics Database (with Foundation Medicine) for a natural-history study of 743 KRAS G12C patients supporting Lumakras FDA approval
- 03Used Flatiron's Spotlight database for benchmark/indirect-comparison analyses supporting the mobocertinib (Exkivity, EGFR Exon20ins) regulatory/HTA submission
- 04Used de-identified Flatiron EHR data to study unmet need in mantle cell lymphoma post-cBTKi therapy, supporting FDA accelerated approval of pirtobrutinib
- 05Used Flatiron real-world data to compare overall survival of niraparib maintenance therapy vs. active surveillance in recurrent ovarian cancer
- 06Used EHR-derived RWD to identify low-LVEF metastatic breast cancer patients on Kadcyla (T-DM1), fulfilling a post-approval regulatory commitment and securing label updates in the US/EU/Canada
- 07Partnered with Flatiron to design a prospective clinico-genomic study using routine-care data for advanced lung cancer patients
- 08Adopted Flatiron Assist clinical decision support, reaching 84% clinician adoption and high preferred-regimen use within 14 months
- 09Adopted Flatiron Assist, achieving high concordance with NCCN Guidelines and faster adoption of novel therapies
- 10Replaced paper research logs with electronic adverse-event documentation in OncoEMR, cutting investigator sign-off time to ~5 hours
- 11Used Flatiron's automated 505(b)(2) ingredient drug-substitution feature in OncoEMR to streamline formulary management
- 12Praised Flatiron Assist for quick, intuitive point-of-care treatment navigation
- 13Praised OncoEMR's usability
- 14Natural-history study comparing early-onset gastric/colorectal cancer prevalence in Japan vs. the US using EHR-derived RWD
TriNetX14
- 01Used TriNetX to streamline clinical trial site identification/outreach, replacing manual/paper processes and raising site acceptance rates from 17% to 32%
- 02Partnered on a technology-driven approach to trial feasibility assessment and site selection, expanding recruitment beyond their traditional site network
- 03Used TriNetX RWD and predictive analytics to improve clinical trial enrollment for systemic lupus erythematosus (SLE) research
- 04Accessed data on ~200,000 burn patients to rapidly analyze rare burn conditions, uncovering mortality-rate and drug-related findings
- 05Joined the TriNetX network for access to 68M+ de-identified patient records across 49 organizations, expanding research and publication output
- 06Completed analytics work in 3 months that previously took 3–4 years, streamlining clinical-trial participant identification
- 07Used TriNetX data to demonstrate feasibility and win a grant studying COVID-19/thrombosis risk in sickle cell disease patients
- 08Increased incoming clinical trial leads 20–30x and published a hydroxychloroquine/COVID-19 outcomes study
- 09Conducted retrospective studies on the mental-health and neurological impacts of COVID-19, publishing in Lancet Psychiatry and PLOS Medicine
- 10Joined TriNetX for trial-opportunity access and RWD from 40+ organizations, generating 200+ trial opportunities and 19 publications in one year
- 11Implemented the TriNetX LIVE platform to automate patient recruitment, replacing manual feasibility estimation with data-driven assessment
- 12Embedded real-world data and AI earlier in trial planning to accelerate study-design decisions
- 13Examines why clinical AI models require local/regional validation to perform reliably across geographies
- 14Applied AI-driven, human-in-the-loop extraction from unstructured clinical notes to recover smoking-status data, improving data completeness and trial-feasibility/AI performance
Symphony Health10
- 01Used Symphony Health's Integrated Dataverse (IDV®) claims data + machine learning to identify undiagnosed lung cancer patients pre-diagnosis, for targeted diagnostic-tool deployment
- 02Used Symphony Health's IDV® to build a longitudinal psoriasis patient/prescriber cohort guiding launch strategy for an oral TYK2 inhibitor
- 03Symphony Health RWD analysis showing access barriers to branded CGRP migraine therapies disproportionately affect marginalized populations
- 04Symphony Health conducted a line-of-therapy analysis on pulmonary arterial hypertension patients to inform commercialisation strategy
- 05Symphony Health data powered privacy-safe, cookie-free digital ad targeting: 41% greater reach, 50% lower cost-per-diagnosed-patient
- 06Symphony Health + HealthWise Data used ML on integrated claims/environmental data to quantify how social determinants of health affect Type 2 diabetes treatment persistence
- 07Symphony Health evaluated whether a glucose-tracking wellness app could lower A1c levels and costs for Type 2 diabetes patients, to support payer adoption
- 08Symphony Health's proprietary audience model outperformed rival data partners in compliantly reaching rare (lung) disease patients for an unbranded education campaign
- 09Symphony Health measured a cardiovascular hospital-based point-of-care marketing campaign, showing statistically significant patient conversion lifts
- 10Symphony Health built a privacy-compliant, DMA-level/ML measurement approach for a social campaign, hitting 90% of standard-method accuracy under stricter privacy rules
Komodo Health9
- 01Collaborated with Komodo to modernize healthcare quality measurement using real-world data and healthcare-native AI
- 02Scaled an AI-powered intelligence platform enterprise-wide, cutting reporting cycles from months to hours
- 03Used real-world patient data to identify gaps in prostate cancer screening and care delivery
- 04Testimonial on Komodo's platform value
- 05Testimonial on Komodo's platform value
- 06Testimonial on Komodo's platform value
- 07Testimonial on Komodo's platform value
- 08"Iris Commercial Case Study" — A mid-size pharmaceutical company launching a rare-condition therapeutic used Komodo's Iris solution/Healthcare Map to grow targeted HCPs ~3x (539 → 1,414) and raised full-year financial guidance 44–60%
- 09Payer case study — A payer relying on siloed datasets joined its own data with Komodo's Healthcare Map to analyze full patient journeys, understand disease-prevalence trends by geography, target engagement, and cut downstream healthcare costs
Truveta5
- 01Compared its EKOS Endovascular System to Inari Medical's FlowTriever for pulmonary embolism treatment using Truveta Data, finding a higher bleeding risk with the competitor device; the "REAL-PE" study was published and presented within 5 months, versus the years/millions an RCT would have required
- 02Used Truveta Data to build the TREAT-AHF heart-failure registry (~165,000 acute decompensated heart failure patient journeys, ~3x the ADHERE registry), validating its decongestion device and optimizing clinical trial design/enrollment predictions
- 03Used Truveta Data to compare hemodialysis catheter designs across multiple health systems, evaluating infection risks and usage trends to guide product safety and development
- 04Analyzed real-world incidence and prevalence of arrhythmias among epilepsy patients to investigate potential cardiac risks associated with anti-seizure medications
- 05Partnered with Truveta (via Truveta Live Link) to securely link its continuous glucose monitoring (CGM) data with longitudinal EHR records for 200,000+ patients, enabling research into kidney disease progression, risk stratification, and real-world CGM therapy effectiveness